J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onochie, C. I
Right arrow Articles by Mulligan, L. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onochie, C. I
Right arrow Articles by Mulligan, L. M
J Med Genet 2000;37:674-679 ( September )

Characterisation of the human GFRalpha -3 locus and investigation of the gene in Hirschsprung disease

Chinedu I Onochie, Lawrence M Korngut, Judith B Vanhorne, Shirley M Myers, Denise Michaud, Lois M Mulligan

Departments of Pathology and Paediatrics, Queen's University, 20 Barrie Street, Kingston, ON K7L 3N6, Canada

Correspondence to: Dr Mulligan, Department of Paediatrics, Queen's University, 20 Barrie Street, Kingston, ON K7L 3N6, Canada, mulligal{at}post.queensu.ca

Revised version received 1 May 2000; Accepted for publication 11 May 2000

BACKGROUND---The GDNF family receptor alpha (GFRalpha ) proteins are extracellular cell surface bound molecules that act as adapters in binding of the GDNF family of soluble neurotrophic factors to the RET receptor. These molecules are essential for development of many neural crest derived cell types and the kidney. Mutations in RET and in two members of the GDNF ligand family are associated with Hirschsprung disease (HSCR), a congenital absence of the enteric ganglia. Members of the GFRalpha family are also candidates for HSCR mutations. One such gene is GFRalpha -3, which is expressed in the peripheral nervous system and developing nerves.
OBJECTIVE---We have characterised the structure of the human GFRalpha -3 locus and investigated the gene for sequence variants in a panel of HSCR patients.
METHODS---Long range PCR or subcloning of PAC clones was used to investigate GFRalpha -3 intron-exon boundaries. A combination of single strand conformation polymorphism (SSCP) analysis and direct sequencing was used to investigate GFRalpha -3 sequence variants.
RESULTS---GFRalpha -3 spans eight coding exons and has a gene structure and organisation similar to that of GFRalpha -1. We identified three polymorphic variants in GFRalpha -3 in a normal control population, a subset of which also occurred in HSCR patients. We did not detect any sequence variants within the coding sequence of GFRalpha -3. We found a base substitution in the 5' UTR of GFRalpha -3, 15 base pairs upstream of the translation start site. A second substitution was identified in intron 4 (IVS4-30G>A) between the splice branch site and the splice acceptor site. The final variant was a 2 base pair insertion within the splice donor consensus sequence of exon 7 (IVS7+4ins GG).
CONCLUSIONS---We did not detect any correlation between variants of GFRalpha -3 and the HSCR phenotype. Our data suggest that mutations of this gene are not a cause of HSCR.


Keywords: GFRalpha -3; Hirschsprung disease; RET


© 2000 by J Med Genet



This article has been cited by other articles:


Home page
J. Med. Genet.Home page
S Borrego, R M Fernandez, H Dziema, A Niess, M Lopez-Alonso, G Antinolo, and C Eng
Investigation of germline GFRA4 mutations and evaluation of the involvement of GFRA1, GFRA2, GFRA3, and GFRA4 sequence variants in Hirschsprung disease
J. Med. Genet., March 1, 2003; 40(3): e18 - 18.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. S. Subramanian, J. S. Marchant, I. Parker, and H. M. Said
Cell Biology of the Human Thiamine Transporter-1 (hTHTR1). INTRACELLULAR TRAFFICKING AND MEMBRANE TARGETING MECHANISMS
J. Biol. Chem., January 31, 2003; 278(6): 3976 - 3984.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Oishi, S. Hofmann, G. A. Diaz, T. Brown, D. Manwani, L. Ng, R. Young, H. Vlassara, Y. A. Ioannou, D. Forrest, et al.
Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice
Hum. Mol. Genet., November 1, 2002; 11(23): 2951 - 2960.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd.